Nilka Ríos Burrows1, YanFeng Li2, Edward W Gregg2, Linda S Geiss2. 1. Division of Diabetes Translation, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA nrios@cdc.gov. 2. Division of Diabetes Translation, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA.
Abstract
OBJECTIVE: Reductions in heart attack and stroke hospitalizations are well documented in the U.S. population with diabetes. We extended trend analyses to other cardiovascular disease (CVD) conditions, including stroke by type, and used four additional years of data. RESEARCH DESIGN AND METHODS: Using 1998-2014 National (Nationwide) Inpatient Sample (NIS) data, we estimated the number of discharges having acute coronary syndrome (ACS) (ICD-9 codes 410-411), cardiac dysrhythmia (427), heart failure (428), hemorrhagic stroke (430-432), or ischemic stroke (433.x1, 434, and 436) as first-listed diagnosis and diabetes (250) as secondary diagnosis. Hospitalization rates for adults aged ≥35 years were calculated using estimates from the population with and the population without diabetes from the National Health Interview Survey (NHIS) and age-adjusted to the 2000 U.S. standard population. Joinpoint regression was used to analyze trends and calculate an average annual percentage change (AAPC) with 95% confidence limits (CLs). RESULTS: From 1998 to 2014, in the population with diabetes, age-adjusted hospitalization rates declined significantly for ACS (AAPC -4.6% per year [95% CL -5.3, -3.8]), cardiac dysrhythmia (-0.7% [-1.1, -0.2]), heart failure (-3.6% [-4.6, -2.7]), hemorrhagic stroke (-1.1% [-1.4, -0.7]), and ischemic stroke (-2.9% [-3.9, -1.8]). In the population without diabetes, rates also declined significantly for these conditions, with the exception of dysrhythmia. By 2014, rates in the population with diabetes population remained two to four times as high as those for the population without diabetes, with the largest difference in heart failure rates. CONCLUSIONS: CVD hospitalization rates declined significantly in both the population with diabetes and the population without diabetes. This may be due to several factors, including new or more aggressive treatments and reductions in CVD risk factors and CVD incidence.
OBJECTIVE: Reductions in heart attack and stroke hospitalizations are well documented in the U.S. population with diabetes. We extended trend analyses to other cardiovascular disease (CVD) conditions, including stroke by type, and used four additional years of data. RESEARCH DESIGN AND METHODS: Using 1998-2014 National (Nationwide) Inpatient Sample (NIS) data, we estimated the number of discharges having acute coronary syndrome (ACS) (ICD-9 codes 410-411), cardiac dysrhythmia (427), heart failure (428), hemorrhagic stroke (430-432), or ischemic stroke (433.x1, 434, and 436) as first-listed diagnosis and diabetes (250) as secondary diagnosis. Hospitalization rates for adults aged ≥35 years were calculated using estimates from the population with and the population without diabetes from the National Health Interview Survey (NHIS) and age-adjusted to the 2000 U.S. standard population. Joinpoint regression was used to analyze trends and calculate an average annual percentage change (AAPC) with 95% confidence limits (CLs). RESULTS: From 1998 to 2014, in the population with diabetes, age-adjusted hospitalization rates declined significantly for ACS (AAPC -4.6% per year [95% CL -5.3, -3.8]), cardiac dysrhythmia (-0.7% [-1.1, -0.2]), heart failure (-3.6% [-4.6, -2.7]), hemorrhagic stroke (-1.1% [-1.4, -0.7]), and ischemic stroke (-2.9% [-3.9, -1.8]). In the population without diabetes, rates also declined significantly for these conditions, with the exception of dysrhythmia. By 2014, rates in the population with diabetes population remained two to four times as high as those for the population without diabetes, with the largest difference in heart failure rates. CONCLUSIONS: CVD hospitalization rates declined significantly in both the population with diabetes and the population without diabetes. This may be due to several factors, including new or more aggressive treatments and reductions in CVD risk factors and CVD incidence.
Authors: William K Mountford; Daniel T Lackland; Jeremy B Soule; Kelly J Hunt; Stuart R Lipsitz; John A Colwell Journal: Ethn Dis Date: 2008 Impact factor: 1.847
Authors: Jing Wang; Linda S Geiss; Yiling J Cheng; Giuseppina Imperatore; Sharon H Saydah; Cherie James; Edward W Gregg Journal: Diabetes Care Date: 2011-05-20 Impact factor: 19.112
Authors: Xuanping Zhang; Heather M Devlin; Bryce Smith; Giuseppina Imperatore; William Thomas; Felipe Lobelo; Mohammed K Ali; Keri Norris; Stephanie Gruss; Barbara Bardenheier; Pyone Cho; Isabel Garcia de Quevedo; Uma Mudaliar; Christopher D Jones; Jeffrey M Durthaler; Jinan Saaddine; Linda S Geiss; Edward W Gregg Journal: PLoS One Date: 2017-05-11 Impact factor: 3.240
Authors: Earl S Ford; Umed A Ajani; Janet B Croft; Julia A Critchley; Darwin R Labarthe; Thomas E Kottke; Wayne H Giles; Simon Capewell Journal: N Engl J Med Date: 2007-06-07 Impact factor: 91.245
Authors: Jessica L Harding; Meda E Pavkov; Dianna J Magliano; Jonathan E Shaw; Edward W Gregg Journal: Diabetologia Date: 2018-08-31 Impact factor: 10.122
Authors: Thibaut Davy-Mendez; Sonia Napravnik; Joseph J Eron; Stephen R Cole; David Van Duin; David A Wohl; Kelly A Gebo; Richard D Moore; Keri N Althoff; Tonia Poteat; M John Gill; Michael A Horberg; Michael J Silverberg; Ni Gusti Ayu Nanditha; Jennifer E Thorne; Stephen A Berry Journal: AIDS Date: 2021-07-01 Impact factor: 4.632
Authors: Aya Tabbalat; Soha Dargham; Jassim Al Suwaidi; Samar Aboulsoud; Salman Al Jerdi; Charbel Abi Khalil Journal: Sci Rep Date: 2021-04-15 Impact factor: 4.379
Authors: S McGurnaghan; L A K Blackbourn; E Mocevic; U Haagen Panton; R J McCrimmon; N Sattar; S Wild; H M Colhoun Journal: Diabet Med Date: 2018-10-10 Impact factor: 4.359